StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
The company has a market capitalization of $833,000.00, a price-to-earnings ratio of 0.00 and a beta of -0.90. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99.
About Athersys
Read More
- Five stocks we like better than Athersys
- Investing in Travel Stocks Benefits
- Google Is Betting Big on Nuclear Reactors—Should You?
- 3 REITs to Buy and Hold for the Long Term
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- Where Do I Find 52-Week Highs and Lows?
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
